Practice Areas
Ro focuses on cutting-edge technology and biotech transactions and has guided his clients through high-stakes public and private mergers and acquisitions, venture capital financings, and securities offerings representing an aggregate value of more than $285 billion. He’s also one of the go-to M&A advisors for complex cross-border transactions in these areas.
In recent years, Ro led the Cooley team advising Horizon Therapeutics on its $28.3 billion agreement to sell to Amgen, which represented the largest healthcare deal of 2022 and the third-largest all-cash healthcare deal in history at the time of announcement. Ro also led the Cooley team advising Japanese payments platform Paidy on its $2.7 billion sale to PayPal, which was named M&A Deal of the Year at the International Financial Law Review’s 2022 Asia-Pacific Awards.
Ro is highly sought after by boards of directors and special committees for his in-depth understanding and extensive experience in activist defense, proxy contests and corporate governance matters.